|
KLRS Kalaris Therapeutics Inc 1754068 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-11,515,000.00 |
| Balance Sheet |
|
Current Assets
|
$95,921,000.00 |
|
Assets
|
$99,539,000.00 |
|
Current Liabilities
|
$8,738,000.00 |
|
Liabilities
|
$41,867,000.00 |
|
Equity
|
$57,672,000.00 |
|
Shares Out
|
23804981.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,627,000.00 |
|
Investing Cash Flow
|
$-30,181,000.00 |
| Market Analysis |
Market Cap
|
$98,076,521.72 |
|
Price
|
$4.12 |
|
BVPS
|
2.42 |
|
PB
|
1.70 |
|
EPS
|
-0.48 |
|
FCF
|
$-22,827,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KLRS documents filed with the SEC.
KLRS Filings
Clear
